A detailed history of Promethium Advisors,Llc transactions in Johnson & Johnson stock. As of the latest transaction made, Promethium Advisors,Llc holds 24,320 shares of JNJ stock, worth $4.59 Million. This represents 2.26% of its overall portfolio holdings.

Number of Shares
24,320
Previous 22,864 6.37%
Holding current value
$4.59 Million
Previous $3.79 Billion 2.03%
% of portfolio
2.26%
Previous 2.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

BUY
$146.36 - $159.82 $213,100 - $232,697
1,456 Added 6.37%
24,320 $3.71 Billion
Q1 2025

May 15, 2025

BUY
$142.06 - $167.7 $412,258 - $486,665
2,902 Added 14.54%
22,864 $3.79 Billion
Q4 2024

Feb 11, 2025

BUY
$143.34 - $165.86 $632,559 - $731,940
4,413 Added 28.38%
19,962 $2.89 Billion
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $2.26 Million - $2.6 Million
15,549 New
15,549 $2.52 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $493B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Promethium Advisors,Llc Portfolio

Follow Promethium Advisors,Llc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Promethium Advisors,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Promethium Advisors,Llc with notifications on news.